Abstract
Pemphigus foliaceus (PF) is one of the two main forms of pemphigus and is characterized by circulating IgG to the desmosomal cadherin desmoglein 1 (DSG1) and by subcorneal blistering of the skin. The pathomechanism of blister formation in PF is unknown. Previously we have shown that PF IgG induces aggregation of DSG1, plakoglobin (PG), and IgG outside of desmosomes, what in immunofluorescence of PF patient skin visualizes as a granular IgG deposition pattern with a limited number of coarse IgG aggregates between cells. Here we have investigated the fate of these aggregates in skin and found that these are cleared by endocytosis. We performed double immunofluorescence staining on snap-frozen skin biopsies of six PF patients for the following molecules: IgG, the desmosomal proteins DSG1 and DSG3, desmocollins 1 and 3, PG, desmoplakin and plakophilin 3, and for the endosomal marker early endosomal antigen 1 and the lysosomal markers cathepsin D and lysosomal-associated membrane protein 1. Endosomes were present in all cells but did not make contact with the aggregates in the basal and suprabasal layers. In the higher layers they moored to the aggregates, often symmetrically from two adjacent cells, and IgG, DSG1, and PG were taken up. Finally these endosomes became localized perinuclear. Endocytosis was only observed in perilesional or lesional skin but not in non-lesional skin. Older immunoelectron microscopic studies have suggested that in PF skin endocytosis of detached desmosomes takes place but we found no other desmosomal proteins to be present in these endosomes. Double staining with cathepsin D and LAMP-1 revealed no overlap with IgG, DSG1, or PG suggesting that lysosomes have no role in the clearing process. Collectively, our results show that endocytosis is part of the pathogenic process in PF but that no detached desmosomes are taken up but instead the deposited IgG is taken up together with DSG1 and PG.
Introduction
Pemphigus is an autoimmune blistering disease of the skin and mucous membranes, which is characterized by a loss of cell-cell adhesion, known as acantholysis. Pemphigus foliaceus (PF) is one of the two major forms of pemphigus and it is characterized by blistering of the skin only and immunologically by circulating autoantibodies against desmoglein 1 (DSG1) (1, 2). DSG1 is a glycoprotein of desmosomes and is expressed through all the epidermal layers. Desmosomes are intercellular adhesion structures and are build-up of transmembrane desmosomal cadherins desmogleins and desmocollins (DSC), that by heterophilic interaction directly interconnect two opposite half-desmosomes, and intracellular desmosomal plaque proteins including plakoglobin (PG), desmoplakin (DP), and plakophilins (PKP) (3–6). The intracellular proteins connect the cytoplasmic tails of the desmosomal cadherins to the intermediate keratin filaments thereby providing strength to the tissue. The pathomechanism of the loss of cell-cell adhesion in PF is not exactly known and compared to PV only few studies have addressed it. It is clear that the anti-DSG1 IgG is the pathogenic factor that induces acantholysis as injection of PF IgG causes skin blistering in mice and in an ex vivo living human skin model (7–9). Injecting of PF IgG in mice also results in activation of p38MAPK and an inhibitor to p38MAPK abolishes this blistering (7). Waschke et al. showed that PF IgG reduces Rho A activity and in an ex vivo human skin model PF induced blistering could be abrogated by Rho A activation (10). Recent research by Walter et al. found that anti-DSG3 IgG and anti-DSG1 IgG led to activation of different signaling pathways. While both activated p38MAPK, anti-DSG3 activated Src while in contrast anti-DSG1 activated ERK, indicating that the pathomechanisms between PV and PF might differ (11). Steric hindrance i.e., obstruction of DSG transinteraction is also considered as a possible pathomechanism. Based on single molecule atomic force measurements and by laser trapping of surface- bound DSG1-coated microbeads Waschke et al. however found no evidence for this (12). We have shown that in the anti-DSG1 IgG induces a shift in distribution of DSG1 and PG in PF patient skin (8). In healthy human skin staining for DSG1 shows an evenly distributed signal over the cell membranes in line with a desmosomal distribution while instead in PF skin, especially in the lower epidermal layers, DSG1 is present in coarse clusters that also contain PG and IgG but no other desmosomal proteins. These clusters can be induced by bivalent PF IgG in the ex vivo living human skin model, but not by monovalent Fab fragments of this same IgG which suggest that crosslinking of DSG molecules underlies cluster formation (8, 9). Recently further evidence was provided that the polyvalence of bivalent PF IgG is responsible for clustering. A mixture of non-pathogenic PF monoclonal antibody (mAb) and pathogenic PF mAb is needed to induce clusters, but only pathogenic PF mAb is able to induce the loss of cell-cell adhesion (13). The clusters in PF skin contain DSG1 and PG, but no other desmosomal components which suggests that desmosomes become depleted of DSG1 (8). In skin where IgG has induced clustering of DSG1 desmosomes become reduced in size and number (14). The reduction in size of the desmosomes can be induced in ex vivo living human skin by both pathogenic or non-pathogenic PF mAb, while their mixture enhances this effect (13).
Tada and Hashimoto (15) studied patient skin by immunoelectron microscopy and found what they called curvicircular cytoplasmic bodies in PF but not in PV skin. These were present in the higher, but not in the lower layers of the epidermis. These structures labeled positive for DSG1, PG, IgG, and connexin 43 (CNX43), and did not contain attachment plaques or inserted tonofilaments. These were hypothesized to be internalized IgG-bound desmosome-gap-junction complexes that transformed into curvicircular structures. In 1999, Iwatsuki et al. described cytoplasmic vesicles in acantholytic keratinocytes that labeled positive for DSG1 and seemed to contain detached desmosomes. We recently described the curvicircular structures to be double membrane structures, that may look intracellular but in fact seem the result of closely sealed (40 nm width) neighboring membranes (www.nanotomy.org). In perilesional skin they are present in the lower epidermal layers and they spread upwards to higher layers in lesional skin (16). We have speculated that these double membrane structures likely are the DSG1-PG-IgG clusters seen by light microscopy.
In order to further unravel the pathomechanism of PF we address in the present the faith of DSG1-PG-IgG clusters and investigate if endocytosis of DSG1 takes place in PF patient skin.
Materials and Methods
Patient Biopsies
We included 6 PF patients; from these 5 had a biopsy from lesional skin, 1 from perilesional skin, and from three patients we also had a concomitant biopsy from healthy skin.
The diagnosis in all six patients had been established on clinical criteria and laboratory investigation, including histology, positive immunofluorescence of skin (DIF), positive binding of serum IgG (1/40 dilution) to monkey esophagus in an epithelial cell surface (ECS) pattern, and serum anti-DSG1 antibodies by MESACUP-2 ELISA test for anti-DSG1 (MBL, Japan). The skin specimens had been immediately frozen in liquid nitrogen and stored at −80°C. Skin obtained from breast reduction was used as healthy control skin. According to national regulations this type of retrospective non-interventional study on leftover tissue from diagnostics does not need approval from the local medical ethical committee.
Immunofluorescence Microscopy
The procedure for immunofluorescence staining and image collection has been described in detail before (8). For visualization of adhesion molecules we used the following monoclonals: DSG1-P23 and DSG1-P124 (DSG1 ectodomain), 27B2, DG3.10, 18D4 and B-11 (DSG1 endodomain), DSG-G194 (DSG3), U100 (DSC1), U114 (DSC3), 15F11 (PG), DP2.15 (DP), and PKP3-270.6.2 (PKP3). Early endosomal antigen (EEA1) was stained with 14/EEA1, cathepsin D (CTS D) was stained with CTD-19, LAMP-1 with H4A3, and connexin 43 with 4E6.2. Double staining of IgG and adhesion molecules IgG was performed with fluoresceinthiocyanate (FITC)-conjugated Fcγ-specific goat F(ab')2 anti-human IgG (Protos Immunoresearch, Burlingame, CA, U.S.A) and Alexa 568-conjugated goat anti-mouse IgG (Molecular Probes Eugene, OR, U.S.A) as secondary steps. For double staining with two different mouse monoclonals we used Zenon® Mouse IgG Labeling Kits Alexa Fluor®488 and Alexa Fluor®568 (Molecular Probes, Invitrogen, USA) by following technical protocols. Supplementary Table 1 contains details on antibodies used.
Results
Endosomal Uptake Takes Place in the Upper Layers of Lesional Pemphigus Foliaceus Skin
In order to examine the fate of DSG1, PG, and IgG clusters, we double stained the perilesional and lesional biopsies for EEA1 and IgG. In 4 of the 6 biopsies EEA1 colocalized with IgG demonstrating that IgG is taken up in endosomes. This is most prominent in the higher epidermal layers, next to and beneath the blister (Figure 1A). In more differentiated cells these endosomes are largely localized perinuclear (Figure 1B). In the 3 biopsies of non-lesional skin of our PF patients no endocytosis was observed. Figure 2 compares endocytosis of PG in non-lesional skin with perilesional or lesional skin of the same patients. In normal healthy human skin no overlap of EEA1 and PG was observed (Figure 2).
Figure 1
Figure 2
Endosomes Contain Desmoglein 1 and Plakoglobin but No Other Desmosomal Proteins
Apart from IgG and PG also DSG1 is present in the same endosomes. In order to examine if other desmosomal components are also endocytosed we examined the localization of other desmosmal proteins in relation to the EEA1/DSG1/PG clusters. No overlap was found. Figure 3 shows colocalization of EEA1 with DSG1 but not with DSG3 and DSC3. Where DSG1 and PG (Figure 4) colocalized in the intercellular vesicles no co-localization of DSG1 with other desmosomal proteins was observed (Figures 5–8). The absence of desmosomal proteins as for instance DP in the clusters suggests that extra-desmosomal rather than desmosomal DSG1 is endocytosed.
Figure 3
Figure 4
Figure 5
Figure 7
Figure 6
Figure 8
Endosomal Uptake Starts From the IgG Clusters
In the basal layer endosomes do not contact the IgG clusters (Figure 9C). Upwards in the spinal layer endosomes moor on to the clusters and internalization starts to take place (Figure 9B). Then finally they become localized perinuclear (Figure 9A). Confocal microscopy shows that the endocytosis from the cluster takes place symmetrically in both cells that share the cluster (Figure 9D, white arrows).
Figure 9
Endosomes Do Not Contain Connexin 43 and Do Not Fuse With Lysosomes
Double staining of DSG1 and CNX43 showed that both were present in intracellular vesicles but these did not colocalize, implying they originate from different mechanisms (Figure 10). Surprisingly CTS D and LAMP-1 did also not colocalize with DSG1 indicating that lysosomes are not a destiny of the IgG-DSG1-PG clusters (Figure 10).
Figure 10
Discussion
In this study we demonstrate that the clustered deposits of IgG in PF patient skin are cleared by endocytosis together with the co-clustered components DSG1 and PG (8). Although clusters are present in the basal epidermal layers active endocytosis starts in the spinous layer. Endocytosis is symmetrical in the way that in takes simultaneously place in both cells that share the cluster and progresses in more differentiated keratinocytes toward the cell nucleus.
Tada and Hashimoto suggested that binding of PF autoantibodies induce internalization of intact desmosomes and gap junctions in form of curvicircular structures that contained IgG, DSG1, PG, and CNX43 (15). Our double labeling results however show that CNX43 is present in separate organelles that are likely internalized annular gap junctions (17). Furthermore we did not find internalizations that contained other desmosomal components meaning that endocytosis of intact or half-desmosomes does not take place in PF skin as suggested before (18). Cirillo et al. demonstrated internalization of DSG1 upon incubation with PF patient sera in a monolayer of cultured cells (19). Cultured cells have characteristics of cells from the basal epidermal layer and no internalization of DSG1 was seen in the basal cells in any of PF biopsies. Therefore, it seems that conclusions reached with cell models have to be interpreted with care.
In contrast with PF, PV was extensively studied in cultured cells and it is shown that PV IgG upon incubation is taken up by endocytosis together with DSG3 and PG (20–23). After 3 h the IgG-DSG3-PG complex colocalized with lysosomes which suggests that cultured cells degrade internalized IgG. However, in PF patient skin we could not find evidence for such a degradation pathway. This suggests that internalized PF-IgG containing endosomes remain in the cell and are finally lost by desquamation. Furthermore in cell monolayer experiments it was shown that upon incubation PV IgG rapidly depletes soluble DSG3 from the membrane followed later by disappearance of desmosomal DSG3 (20, 21). Jennings et al. showed that prior to its internalization insoluble DSG3 is reorganized together with other desmosomal proteins into structures that are perpendicular to the cell membranes that were named linear arrays (23). Stahley et al. by super resolution microscopy observed structures in mucocutaneous PV skin they believed to be the linear arrays from which endocytosis of insoluble DSG3 takes place (24). Although we used simple immunofluorescence microscopy our data do not in any way suggest that such arrays are present in PF skin. Therefore, PV and PF pathogenesis might differ in the way IgG and DSG1 are endocytosed. An indication for this is that in PV skin colocalization of IgG and EEA1 was present in multiple small puncta near the cell membranes while we observed in PF skin that colocalization of IgG and EEA1 is in very large endosomes and only in the upper epidermal layers (24). Furthermore unlike in PV skin endocytosis in PF skin is restricted to the clusters that are induced by the anti-DSG1 IgG only.
Taken together we propose the following sequence of the events in PF patient skin. PF IgG binding to non-desmosomal DSG1 induces clustering and reorganization of non-desmosomal DSG1 together with PG which is bound to the cytoplasmic tail of DSG1. As other molecules as DP are absent desmosomal DSG1 is likely not included in these clusters. This causes lack of DSG1 in desmosomal turnover resulting in depletion of DSG1 from desmosomes and reduction of their size. Reorganized DSG1-PG-IgG are trapped into clusters which are likely the double membrane structures seen by electron microscopy (16). Proteins from these clusters are taken up in endosomal compartments in the upper epidermal layers. This endosomes remain perinuclear until removed with desquamation of keratinocytes. Due to depletion of desmosomes from DSG1 and absence of compensatory DSG3 in the subcorneal layer desmosomes will weaken and finally “melt” away here what leads to blistering. Future research has to address how previous observations on effects of PF serum on signal transduction and the activation of signal transduction molecules are connected to the ultrastructural findings. What does emerge from this and previous studies is that many factors have to be taken into consideration, which complicates such research. For instance why acantholysis only occurs when DSG3 is absent, meaning that whatever is the primary cause of acantholysis, steric hindrance, signal transduction or DSG1 depletion, neither one of them is able to induce acantholysis when DSG3 is still present. It is possible that clustering is a main cause of DSG1 depletion of desmosomes, but PF blisters can also be induced in organ culture in the absence of clustering (8, 10). Then for endocytosis of DSG1 it is unclear why it is absent in the basal layer, although endosomes are present here. Clustering starts in the basal layer as this is the first layer that encounters the pathogenic PF IgG, so something must be missing to start endocytosis.
Statements
Data availability statement
All datasets generated for this study are included in the article/Supplementary Material.
Author contributions
DO, HP, and MJ contributed to the design of the study. DO, DK, and ES performed the experiments. DO and ES wrote the manuscript. HP and MJ revised the manuscript.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fimmu.2019.02635/full#supplementary-material
References
1.
StanleyJRKouluLKlaus-KovtunVSteinbergMS. A monoclonal antibody to the desmosomal glycoprotein desmoglein I binds the same polypeptide as human autoantibodies in pemphigus foliaceus. J Immunol. (1986) 136:1227–30.
2.
StanleyJRAmagaiM. Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome. N Engl J Med. (2006) 355:1800–10. 10.1056/NEJMra061111
3.
GarrodDChidgeyM. Desmosome structure, composition and function. Biochim Biophys Acta. (2008) 1778:572–87. 10.1016/j.bbamem.2007.07.014
4.
DelvaETuckerDKKowalczykAP. The desmosome. Cold Spring Harb Perspect Biol. (2009) 1:a002543. 10.1101/cshperspect.a002543
5.
KowalczykAPGreenKJ. Structure, function, and regulation of desmosomes. Prog Mol Biol Transl Sci. (2013) 116:95–118. 10.1016/B978-0-12-394311-8.00005-4
6.
HarrisonOJBraschJLassoGKatsambaPSAhlsenGHonigBet al. Structural basis of adhesive binding by desmocollins and desmogleins. Proc Natl Acad Sci USA. (2016) 113:7160–5. 10.1073/pnas.1606272113
7.
BerkowitzPChuaMLiuZDiazLARubensteinDS. Autoantibodies in the autoimmune disease pemphigus foliaceus induce blistering via p38 mitogen-activated protein kinase-dependent signaling in the skin. Am J Pathol. (2008) 173:1628–36. 10.2353/ajpath.2008.080391
8.
OktarinaDAvan der WierGDiercksGFJonkmanMFPasHH. IgG-induced clustering of desmogleins 1 and 3 in skin of patients with pemphigus fits with the desmoglein nonassembly depletion hypothesis. Br J Dermatol. (2011) 165:552–62. 10.1111/j.1365-2133.2011.10463.x
9.
van der WierGPasHHJonkmanMF. Experimental human cell and tissue models of pemphigus. Dermatol Res Pract. (2010) 2010:143871. 10.1155/2010/143871
10.
WaschkeJSpindlerVBruggemanPZillikensDSchmidtGDrenckhahnD. Inhibition of Rho A activity causes pemphigus skin blistering. J Cell Biol. (2006) 175:721–7. 10.1083/jcb.200605125
11.
WalterEVielmuthFRotkopfLSardyMHorvathONGoebelerMet al. Different signaling patterns contribute to loss of keratinocyte cohesion dependent on autoantibody profile in pemphigus. Sci Rep. (2017) 7:3579. 10.1038/s41598-017-03697-7
12.
WaschkeJBruggemanPBaumgartnerWZillikensDDrenckhahnD. Pemphigus foliaceus IgG causes dissociation of desmoglein 1-containing junctions without blocking desmoglein 1 transinteraction. J Clin Invest. (2005) 115:3157–65. 10.1172/JCI23475
13.
YoshidaKIshiiKShimizuAYokouchiMAmagaiMShiraishiKet al. Non-pathogenic pemphigus foliaceus (PF) IgG acts synergistically with a directly pathogenic PF IgG to increase blistering by p38MAPK-dependent desmoglein 1 clustering. J Dermatol Sci. (2017) 85:197–207. 10.1016/j.jdermsci.2016.12.010
14.
van der WierGPasHHKramerDDiercksGFHJonkmanMF. Smaller desmosomes are seen in the skin of pemphigus patients with anti-desmoglein 1 antibodies but not in patients with anti-desmoglein 3 antibodies. J Invest Dermatol. (2014) 134:2287–90. 10.1038/jid.2014.140
15.
TadaJHashimotoK. Curvicircular intracytoplasmic membranous structures in keratinocytes of pemphigus foliaceus. J Cutan Pathol. (1996) 23:511–7. 10.1111/j.1600-0560.1996.tb01443.x
16.
SokolEKramerDDiercksGFHKuipersJJonkmanMFPasHHet al. Large-scale electron microscopy maps of patient skin and mucosa provide insight into pathogenesis of blistering diseases. J Invest Dermatol. (2015) 135:1763–70. 10.1038/jid.2015.109
17.
PiehlMLehmannCGumpertADenizotJPSegretainDFalkMM. Internalization of large double-membrane intercellular vesicles by a clathrin-dependent endocytic process. Mol Biol Cell. (2007) 18:337–47. 10.1091/mbc.e06-06-0487
18.
IwatsukiKHanGWFukutiROhtsukaMKikuchiSAkibaHet al. Internalization of constitutive desmogleins with the subsequent induction of desmoglein 2 in pemphigus lesions. Br J Dermatol. (1999) 140:35–43. 10.1046/j.1365-2133.1999.02604.x
19.
CirilloNGombosFLanzaA. Changes in desmoglein 1 expression and subcellular localization in cultured keratinocytes subjected to anti-desmoglein 1 pemphigus autoimmunity. J Cell Physiol. (2007) 210:411–6. 10.1002/jcp.20856
20.
SatoMAoyamaYKitajimaY. Assembly pathway of desmoglein 3 to desmosomes and its perturbation by pemphigus vulgaris-IgG in cultured keratinocytes, as revealed by time-lapsed labeling immunoelectron microscopy. Lab Invest. (2000) 80:1583–92. 10.1038/labinvest.3780168
21.
CalkinsCCSetzerSVJenningsJMSummersSTsunodaKAmagaiMet al. Desmoglein endocytosis and desmosome disassembly are coordinated responses to pemphigus autoantibodies. J Biol Chem. (2006) 281:7623–34. 10.1074/jbc.M512447200
22.
DelvaEJenningsJMCalkinsCCKottkeMDFaundezVKowalczykAP. Pemphigus vulgaris IgG-induced desmoglein-3 endocytosis and desmosomal disassembly are mediated by a clathrin- and dynamin-independent mechanism. J Biol Chem. (2008) 283:18303–13. 10.1074/jbc.M710046200
23.
JenningsJMTuckerDKKottkeMDSaitoMDelvaEHanakawaYet al. Desmosome disassembly in response to pemphigus vulgaris IgG occurs in distinct phases and can be reversed by expression of exogenous Dsg3. J Invest Dermatol. (2011) 131:706–18. 10.1038/jid.2010.389
24.
StahleySNWarrenMFFeldmanRJSwerlickRAMattheysesALKowalczykAP. Super-resolution microscopy reveals altered desmosomal protein organization in tissue from patients with pemphigus vulgaris. J Invest Dermatol. (2016) 136:59–66. 10.1038/JID.2015.353
Summary
Keywords
pemphigus foliaceus, desmoglein 1, desmosomes, acantholysis, endocytosis
Citation
Oktarina DAM, Sokol E, Kramer D, Jonkman MF and Pas HH (2019) Endocytosis of IgG, Desmoglein 1, and Plakoglobin in Pemphigus Foliaceus Patient Skin. Front. Immunol. 10:2635. doi: 10.3389/fimmu.2019.02635
Received
30 January 2019
Accepted
24 October 2019
Published
12 November 2019
Volume
10 - 2019
Edited by
Cezary Kowalewski, Medical University of Warsaw, Poland
Reviewed by
Ralf J. Ludwig, Universität zu Lübeck, Germany; Jens Waschke, Ludwig Maximilian University of Munich, Germany
Updates
Copyright
© 2019 Oktarina, Sokol, Kramer, Jonkman and Pas.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Hendri H. Pas h.h.pas@umcg.nl
This article was submitted to Autoimmune and Autoinflammatory Disorders, a section of the journal Frontiers in Immunology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.